Corinne Johnson

Stock Analyst at Goldman Sachs

(n/a)

# 4,408

Out of 4,415 analysts

3

Total ratings

n/a

Success rate

-19.35%

Average return

Main Sectors:

Top Industries:

3 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	IMVT Immunovant	Initiates: Buy	$50	$28.78	+73.73%	1	Mar 13, 2024
	AVBP ArriVent BioPharma	Initiates: Buy	$27	$16.80	+60.71%	1	Feb 20, 2024
	CGON CG Oncology	Initiates: Neutral	$42	$39.50	+6.33%	1	Feb 20, 2024

Immunovant

Mar 13, 2024

Initiates: Buy

Price Target: $50

Current: $28.78

Upside: +73.73%

ArriVent BioPharma

Feb 20, 2024

Initiates: Buy

Price Target: $27

Current: $16.80

Upside: +60.71%

CG Oncology

Feb 20, 2024

Initiates: Neutral

Price Target: $42

Current: $39.50

Upside: +6.33%